As of the latest SEC filings, Candel Therapeutics, Inc. (CADL) is held by 105 institutional funds. The largest fund shareholder is Select Biotechnology Portfolio (FBIOX), holding an estimated $31,037,742.75 in market value, representing 0.58% of its portfolio.
Funds holding Candel Therapeutics, Inc. (CADL)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- CADL
- CIK:
- 0001841387
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
FBIOX
Select Biotechnology Portfolio
|
MF | Fidelity | 0.58% | $31,037,742.75 | 5,911,951 | Feb 28, 2026 | Apr 24, 2026 |
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $9,643,366.60 | 1,968,034 | Mar 31, 2026 | May 28, 2026 |
|
FGCKX
Fidelity Growth Company Fund
|
MF | Fidelity | 0.01% | $9,117,003.00 | 1,736,572 | Feb 28, 2026 | Apr 24, 2026 |
|
FSAKX
Strategic Advisers U.S. Total Stock Fund
|
MF | Fidelity | 0.01% | $8,812,933.50 | 1,678,654 | Feb 28, 2026 | Apr 24, 2026 |
|
IWM
iShares Russell 2000 ETF
|
ETF | BlackRock / iShares | 0.01% | $5,465,945.10 | 1,115,499 | Mar 31, 2026 | May 28, 2026 |
|
FSSNX
Fidelity Small Cap Index Fund
|
MF | Fidelity | 0.01% | $2,782,100.04 | 450,178 | Apr 30, 2026 | Jun 26, 2026 |
|
FGKFX
Fidelity Growth Company K6 Fund
|
MF | Fidelity | 0.01% | $2,649,375.75 | 504,643 | Feb 28, 2026 | Apr 24, 2026 |
|
FCGSX
Fidelity Series Growth Company Fund
|
MF | Fidelity | 0.01% | $2,508,660.00 | 477,840 | Feb 28, 2026 | Apr 24, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $2,153,128.60 | 439,414 | Mar 31, 2026 | May 28, 2026 |
|
IWO
iShares Russell 2000 Growth ETF
|
ETF | BlackRock / iShares | 0.01% | $1,593,048.80 | 325,112 | Mar 31, 2026 | May 28, 2026 |
|
IBB
iShares Biotechnology ETF
|
ETF | BlackRock / iShares | 0.02% | $1,445,475.50 | 294,995 | Mar 31, 2026 | May 28, 2026 |
|
VTWO
VANGUARD RUSSELL 2000 INDEX FUND
|
ETF | Vanguard | 0.01% | $1,135,900.50 | 216,362 | Feb 28, 2026 | Apr 28, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.00% | $1,073,068.50 | 204,394 | Feb 28, 2026 | Apr 24, 2026 |
|
SWSSX
Schwab Small-Cap Index Fund
|
MF | Charles Schwab | 0.01% | $597,686.34 | 96,713 | Apr 30, 2026 | Jun 25, 2026 |
|
IWC
iShares Micro-Cap ETF
|
ETF | BlackRock / iShares | 0.05% | $558,413.80 | 113,962 | Mar 31, 2026 | May 28, 2026 |
|
FSKAX
Fidelity Total Market Index Fund
|
MF | Fidelity | 0.00% | $349,655.25 | 66,601 | Feb 28, 2026 | Apr 24, 2026 |
|
BRSIX
Ultra-Small Company Market Fund
|
MF | Independent / Boutique | 0.28% | $343,000.00 | 70,000 | Mar 31, 2026 | May 21, 2026 |
|
-
Master Small Cap Index Series
|
ETF | Independent / Boutique | 0.01% | $333,939.90 | 68,151 | Mar 31, 2026 | May 28, 2026 |
|
TRHBX
Nuveen Small Cap Blend Index Fund
|
MF | TIAA / Nuveen | 0.01% | $316,459.26 | 51,207 | Apr 30, 2026 | Jun 24, 2026 |
|
FCFMX
Fidelity Series Total Market Index Fund
|
MF | Fidelity | 0.00% | $288,156.75 | 54,887 | Feb 28, 2026 | Apr 24, 2026 |
|
GINUX
Goldman Sachs Small Cap Growth Insights Fund
|
MF | Goldman Sachs | 0.10% | $281,727.66 | 45,587 | Apr 30, 2026 | Jun 22, 2026 |
|
SBIO
ALPS Medical Breakthroughs ETF
|
ETF | Independent / Boutique | 0.19% | $256,877.25 | 48,929 | Feb 28, 2026 | Apr 29, 2026 |
|
TINRX
Nuveen Equity Index Fund
|
MF | TIAA / Nuveen | 0.00% | $246,841.56 | 39,942 | Apr 30, 2026 | Jun 24, 2026 |
|
-
EQ/2000 Managed Volatility Portfolio
|
ETF | Independent / Boutique | 0.01% | $222,822.60 | 45,474 | Mar 31, 2026 | May 26, 2026 |
|
VTWG
VANGUARD RUSSELL 2000 GROWTH INDEX FUND
|
ETF | Vanguard | 0.01% | $190,622.25 | 36,309 | Feb 28, 2026 | Apr 28, 2026 |
Advertisement (320x50)